ABSTRACF
muscle THE GENDER DIFFERENCE in the incidence of morbidity and mortality from coronary heart disease is well known. The role of ovarian steroids is being explored by largescale epidemiological studies that show the incidence of coronary heart disease to be relatively low among premenopausal women, with a sharp rise with the occurrence of menopause (1, 2) . The increased risk of coronary heart disease in young women with bilateral oophorectomy (3) and the beneficial effect of estrogen replacement therapy in postmenopausal women (4, 5) further support a role for estrogen in protecting against the development of coronary artery disease.
Estrogen is thought to exert some of its cardiovascular protection by a beneficial effect on plasma lipoproteins: decreasing LDL cholesterol and increasing HDL cholesterol (6). However, the data are mounting that estrogen may also exert its beneficial effects through a direct action on blood vessels.
First, the vascular wall contains specific, high-affinity receptors for estrogen. Second, estrogen affects vascular tone both in vivo and in vitro; and third, inhibits the remodeling associated with vascular injury. Finally, cell culture studies indicate that estrogen directly affects proliferation of both endothelial and vascular smooth muscle cells. In this review, we will discuss the experimental and clinical information regarding the effect of estrogen on cells of the blood vessel wall, and suggest possible mechanisms mediating these effects. in aorta of dog (9), rat (10-12), rabbit (13), and baboon (14, 15), and in smooth muscle cells isolated from rat (16) and human (17) coronary arteries. 
ESTROGEN RECEPTORS

Nongenomic effect of estrogen
It is believed that the rapid vascular effects of estrogen are mediated by a mechanism independent of the classical genomic pathway of steroid action, which involves receptor activation and gene transcription (41 More studies will be needed to characterize these specific membrane estrogen receptors and to determine their role in mediating the short-term nongenomic effects of the hormone.
Other effects of estrogen on vascular reactivity
There are instances, however, where estrogen appears to potentiate the spasmogenic response of vascular smooth muscle preparations.
For example, the isolated perfused lungs from female rats exhibit a greater pressor response to the thromboxane mimic U46619 than those from males, an effect that was attenuated by ovariectomy and restored in ovariectomized animals after estradiol treatment (54). Acute (5 mm) perfusion with nanomolar concentrations of estradiol-17 also causes a significant potentiation of the response of the rat pulmonary (54 
Estrogen and the endothelium-derived relaxing factor
Recent studies have focused on the role of the endothehum-derived NO in mediating the effect of estrogen on vasomotor tone in blood vessels in which the endothelium is intact or has been compromised by immune, chemical, or mechanical injury. Studies suggest that the function of the endothelial L-arginine/nitric oxide pathway may be sexually differentiated. L-arginine was reported to augment the acetylchohine (Ach) -induced increase in forearm blood flow more in control women than in men. Hypercholesterolemia, which is associated with abnormal NO production, caused a significant decrease in the response to Ach in men, but not in women (101). In vitro, Ach and the calcium ionophore A23187 elicited a greater response in segments isolated from female rabbit aorta (102) (102) . Estradiol, on the other hand, increased the activity of the Ca2-dependent NOS in the porcine uterine artery, heart, and skeletal muscle (119) . in skeletal muscle, the amount of mRNA for the NOS isozymes was increased by estradiol, suggesting that the observed increase in NOS activity may be due to enzyme induction.
Estrogen and angiogenesis
Recently, Morales et al. (120) showed that estradiol-i7 enhances attachment of human umbilical vein endothelial cells to different culture surfaces. Estradiol also.increased wound healing of the endothelial cell monolayer and enhanced the ability of endothelial cells to organize into tubular network when plated on matrigel.
Using an in vivo model of neovascularization in which matrigel plugs are coinjected with basic fibroblast growth factor in mice, they also showed that vascularization is markedly decreased with ovariectomy and increased back to normal levels with estrogen treatment. These observations support a role of estrogen in promoting angiogenesis. The clinical applicability of these findings remains to be investigated.
We speculate, however, that the angiogenic effect of estrogen may play a potential role in protecting against coronary ischemic disease. By promoting neovascularization and collateral formation, estrogen may restore myocardial perfusion in ischemic hearts and hence lessen the impact of coronary occlusion.
CONCLUSION
Estrogen appears to exert its cardiovascular protective action, at least in part, by a direct effect on the vessel wall. This hormone may cause vasodilation by altering membrane ionic permeability in vascular smooth muscle or indirectly by regulating the activity of NO and prostacyclin synthases.
Estrogen is also an angiogenic factor and may protect against vascular injury by inhibiting vascular smooth muscle cell migration and proliferation.
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